Different from other cancer subtypes, the overexpression of our identified peptide-derived protein interleukin-1 receptor type 2 promotes the initiation and progression of sarcoma (Boddul et al., 2014; Liu et al., 2015). The gene discussed is IL1R2; the disease is sarcoma.